Guangzhou Baiyunshan Pharmaceutical Holdings Co Ltd (600332) — Capital Reinvestment Ratio
Guangzhou Baiyunshan Pharmaceutical Holdings Co Ltd (600332) has a Capital Reinvestment Ratio of 0.18x as of December 2025, meaning it reinvests 0% of its operating cash flow (CN¥1.84 Billion) in capital expenditures (CN¥330.65 Million). Check Guangzhou Baiyunshan Pharmaceutical Hold tangible book value ratio to evaluate the tangible quality of the company's equity base.
Capital Reinvestment Ratio
Operating Cash Flow
Capital Expenditures
Data as of
Guangzhou Baiyunshan Pharmaceutical Holdings Co Ltd Capital Reinvestment Ratio (2000–2025)
This chart tracks Guangzhou Baiyunshan Pharmaceutical Holdings Co Ltd's Capital Reinvestment Ratio across 24 annual periods. For the full cash flow conversion analysis, see 600332 cash generation efficiency.
Annual Capital Reinvestment Ratio for Guangzhou Baiyunshan Pharmaceutical Holdings Co Ltd (2000–2025)
Year-by-year Capital Reinvestment Ratio for Guangzhou Baiyunshan Pharmaceutical Holdings Co Ltd from 2000 to 2025. See 600332 FCF generation index to measure how efficiently the company converts operating cash flow to free cash.
| Year | Reinvestment Ratio | Operating CF (CNY) | Capital Expenditures | YoY Change |
|---|---|---|---|---|
| 2025 | 4.76x | CN¥260.23 Million | CN¥1.24 Billion | ▲ +1353.9% |
| 2024 | 0.33x | CN¥3.44 Billion | CN¥1.13 Billion | ▼ -17.4% |
| 2023 | 0.40x | CN¥4.10 Billion | CN¥1.63 Billion | ▲ +100.7% |
| 2022 | 0.20x | CN¥7.00 Billion | CN¥1.38 Billion | ▼ -10.6% |
| 2021 | 0.22x | CN¥5.67 Billion | CN¥1.25 Billion | ▼ -85.2% |
| 2020 | 1.50x | CN¥585.19 Million | CN¥876.50 Million | ▲ +213.5% |
| 2019 | 0.48x | CN¥5.02 Billion | CN¥2.40 Billion | ▲ +420.8% |
| 2018 | 0.09x | CN¥5.22 Billion | CN¥478.62 Million | ▼ -14.5% |
| 2017 | 0.11x | CN¥1.83 Billion | CN¥196.77 Million | ▲ +15.0% |
| 2016 | 0.09x | CN¥2.44 Billion | CN¥228.03 Million | ▼ -64.9% |
| 2015 | 0.27x | CN¥1.94 Billion | CN¥515.34 Million | ▲ +32.2% |
| 2014 | 0.20x | CN¥1.76 Billion | CN¥353.65 Million | ▼ -23.3% |
| 2013 | 0.26x | CN¥1.34 Billion | CN¥350.35 Million | ▲ +151.9% |
| 2012 | 0.10x | CN¥506.53 Million | CN¥52.61 Million | ▼ -90.9% |
| 2010 | 1.14x | CN¥73.17 Million | CN¥83.20 Million | ▲ +470.6% |
| 2009 | 0.20x | CN¥439.39 Million | CN¥87.56 Million | ▼ -99.0% |
| 2008 | 20.80x | CN¥6.10 Million | CN¥126.98 Million | ▲ +6271.7% |
| 2007 | 0.33x | CN¥375.74 Million | CN¥122.69 Million | ▼ -86.0% |
| 2006 | 2.33x | CN¥38.88 Million | CN¥90.45 Million | ▲ +173.7% |
| 2005 | 0.85x | CN¥146.32 Million | CN¥124.36 Million | ▼ -44.8% |
| 2004 | 1.54x | CN¥200.54 Million | CN¥308.69 Million | ▲ +49.8% |
| 2002 | 1.03x | CN¥169.01 Million | CN¥173.70 Million | ▼ -10.2% |
| 2001 | 1.14x | CN¥140.15 Million | CN¥160.44 Million | ▲ +100.9% |
| 2000 | 0.57x | CN¥286.95 Million | CN¥163.53 Million | — |